Abpro Holdings, Inc. (ABPO)
OTCMKTS · Delayed Price · Currency is USD
0.378732
-0.003768 (-0.99%)
At close: Sep 29, 2026
Abpro Holdings Market Cap
Abpro Holdings has a market cap or net worth of $2.23 million as of September 29, 2026. Its market cap has decreased by -87.22% in one year.
Market Cap
2.23M
Enterprise Value
-1.28M
Revenue
n/a
Ranking
n/a
PE Ratio
0.74
Stock Price
$0.38
ChartMarket Cap Chart
Since March 9, 2022, Abpro Holdings's market cap has decreased from 4.10B to 2.23M, a decrease of -99.95%. That is a compound annual growth rate of -80.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 2.23M | -80.57% |
| Dec 31, 2025 | 11.49M | -87.30% |
| Dec 31, 2024 | 90.44M | -97.94% |
| Dec 22, 2023 | 4.38B | 3.83% |
| Dec 30, 2022 | 4.22B | 2.93% |
| Mar 9, 2022 | 4.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 2.86M |
| Vaccinex | 2.78M |
| International Stem Cell | 2.60M |
| GPL Holdings | 2.56M |
| CASI Pharmaceuticals | 2.56M |
| BioAtla | 2.53M |
| Bioxytran | 2.42M |
| VitaSpring Biomedical | 2.30M |